This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria (S. pneumoniae)
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
230
To assess the microbiologic efficacy of linezolid in the treatment of patients with pneumonia caused by penicillin-resistant Streptococcus pneumoniae (PRSP).
Additionally, microbiologic efficacy will be assessed in all pneumonia patients infected with S pneumoniae SP) and in those infected with penicillin-sensitive (PSSP) and penicillin-intermediate (PISP) S pneumoniae.
To assess clinical efficacy and safety in pneumonia patients infected with S pneumoniae.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Center
Los Angeles, California, United States
Research Center
Jacksonville, Florida, United States
Research Center
Naples, Florida, United States
Research Center
Savannah, Georgia, United States
Research Center
Springfield, Illinois, United States
Research Center
Baton Rouge, Louisiana, United States
Research Center
Baltimore, Maryland, United States
Research Center
Ann Arbor, Michigan, United States
Research Center
Royal Oak, Michigan, United States
Research Center
Springfield, Missouri, United States
...and 36 more locations